Altogether, the above results demonstrated that inhibiting PI3K/Akt signaling had therapeutic benefits on PTC primary tumor development and metastasis formation, while inhibiting JAK/STAT3 signaling had no beneficial effects on both the primary tumors and the metastases in an orthotopic xenograft model. This evidence concerns the gene STAT3 and neoplasm.